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Abstract
Background: Obesity is closely related to the metabolism of triacylglycerol (TG) in adipocytes. Adipose triglyceride
lipase (ATGL) and hormone-sensitive lipase (HSL) are rate-limiting enzymes that control the hydrolysis of TG. Effects
on ATGL and HSL to increase lipolysis may counteract obesity. Berberine (BBR) is a compound derived from the
Chinese medicine plant Coptis chinensis. In the present study we show the effects of BBR on ATGL and HSL and
explore the potential underlying mechanisms of these effects.
Methods: The TG content in cells was measured using a colorimetric assay. The expressions of HSL, ATGL and
GPAT3 were evaluated by Western-blotting. The expression of ATGL was also evaluated by real-time PCR and
radioimmunoassay. Compound C, an inhibitor of AMP-activated protein kinase (AMPK), was used to explore the
possible pathway that involved in the effect of BBR on ATGL.
Results: TG content of differentiated 3T3-L1 cells was significantly decreased by more than 10% after treated with
BBR. In differentiated 3T3-L1 adipocytes, BBR increased the expression of p-HSL and ATGL, and these effects were
time-depended (p <0.01). The effect of BBR on ATGL expression could be abolished by Compound C which
suggested that AMPK pathway was involved in the effects of BBR on p-HSL and ATGL.
Conclusions: BBR could increase the expression of ATGL and therefore stimulate basal lipolysis in mature
adipocytes through the associated mechanisms related to the AMPK pathway.
Keywords: ATGL, 3T3-L1 cell, HSL, Lipolysis, Obesity
Background
Obesity has become a worldwide public health problem.
It is an established risk factor for metabolic diseases in-
cluding type 2 diabetes, hypertension, coronary heart
disease, and nonalcoholic fatty liver disease [1, 2].
In adults, obesity mainly results from an increase in the
size of adipocytes, that is, the accumulation of triacylglycerol
(TG) in adipocytes. There are several key enzymes that par-
ticipate in the metabolic processing of TG, including
glycerol-3-phosphate acyltransferase 3 (GPAT3), hormone-
sensitive lipase (HSL) and adipose triglyceride lipase
(ATGL). GPAT3 is the major GPAT isoform expressed in
adipocytes and plays a crucial role in adipogenesis. HSL and
ATGL are rate-limiting enzymes that regulate the lipolysis
of TG in adipocytes [3]. They catalyze the hydrolysis of TG
and effect different catabolism courses of TG [4]. ATGL
primarily catalyzes the hydrolysis of TG to generate diacyl-
glycerol (DG) and mediates the hydrolysis of triglycerides
during basal lipolysis [3]. HSL mainly exhibits DG lipase
and is the major lipase for catecholamine- and natriuretic
peptide-stimulated lipolysis. Because of their important roles
in regulating the metabolism of TG, HSL and ATGL have
become common subjects of research regarding obesity and
lipid metabolism.
Berberine (BBR) is a major constituent of the Chinese
herb Rhizoma Coptidis. BBR is known for its antimicrobial,
antiprotozoal, and antidiarrheal activity, and it is commonly
used in clinical practice to treat bacterial diarrhea [5].
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Recently, BBR was found to be involved in the metabolism
of TG when a study showed that BBR directly decreased
catecholamine-stimulated lipolysis by stimulating the
expression of p-HSL in 3T3-L1 adipocytes [6]. However, it
remains unclear whether BBR could directly affect ATGL in
3T3-L1 adipocytes.
AMP-activated protein kinase (AMPK) is a well-
known metabolic master switch. As important rate-
limiting enzymes regulating lipolysis in adipocytes, both
HSL and ATGL could be modified by AMPK [6, 7]. BBR
has been shown to activate AMPK, which contributes to
the beneficial metabolic effects of BBR in peripheral
tissues [8, 9].
Taken together, we suggest that BBR could regulate
the expression of ATGL through the AMPK pathway. In
this study, we tried to verify this hypothesis both in vivo
and in vitro. The results of this study may help us inves-
tigate the direct effects of BBR on ATGL expression in
3T3-L1 adipocytes and the potential mechanism under-
lying these effects. The effect of BBR on ATGL may par-
tially account for the anti-obesity effect of BBR.
Methods
Cell culture and initiation of differentiation
The 3T3-L1 cells were purchased from the American
Type Culture Collection (ATCC). The 3T3-L1 cells were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco BRL, Gaithersburg, MD, USA)
supplemented with 10% (v/v) newborn calf serum (NBS,
Gibco), 100 U/mL penicillin, and 0.1 mg/mL strepto-
mycin (KeyGEN, Nanjing, China) in a humidified 5%
CO2 incubator at 37 °C. D0 was designated as the
second day after the confluence of the 3T3-L1 cells. To
induce differentiation, preadipocytes were treated for
2 days beginning on D0 with 0.5 mmol/L, isobutyl-
methylxanthine (IBMX, Sigma-Aldrich), 2.5 mmol/L
dexamethasone (Dex, Sigma-Aldrich) and 8.7 mmol/L
insulin (Sigma-Aldrich) in DMEM containing 10% fetal
calf serum (FCS, Gibco), followed by treatment for
another 2 days with insulin (10 mM) alone in DMEM
containing 10% FCS. The cells were subsequently
replenished with DMEM containing 10% FCS every
other day. On day 12, approximately 90% of the 3T3-L1
cells had differentiated into mature adipocytes.
Cell stimulation
Differentiated 3T3-L1 adipocytes were starved in serum-
free DMEM for 24 h before stimulation. The cells were
then treated with BBR (National Institutes for Food and
Drug Control, Beijing, China). For experiments with
Compound C (Sigma-Aldrich), the cells were pre-treated
with Compound C for 1 h before stimulation with BBR
according to the experimental design.
Oil red O staining
The cells were washed twice with PBS and fixed with
4% paraformaldehyde for 15 min. After being washed
twice in PBS, the cells were stained for 15 min in
freshly diluted Oil Red O (Sigma) solution. The dishes
were then rinsed in water and counterstained with
hematoxylin for 10 s. Representative photomicrographs
were captured using a system incorporated in the micro-
scope (Axiovert 100 M Zeiss, Zeppelinstrasse, Germany).
Triglyceride quantification
TG content was measured using a colorimetric assay
(Applygen, Beijing, China). To remove glycerol, the cells
were washed with PBS twice before being dissolved in
standard diluent. The mixture was divided into two parts;
500 μl of the mixture was centrifuged at 2000 g for 10 min
and the supernatant was collected. The absorbance of this
dye is proportional to the concentration of TG present in
each sample, and the absorbance was quantified at 550 nm
following these reactions. The protein content of the re-
mainder of the mixture was measured according to BCA
methods. All samples were tested in duplicate, and the TG
values were expressed as mmol of TG/g of protein.
Western blot analysis
The cells were homogenized in RIPA lysis buffer contain-
ing protease inhibitors. The protein concentrations were
measured using the BCA method. Proteins (100 mg) were
separated on 10% SDS-PAGE gels and transferred to a
PVDF membrane (Millipore, USA). The membranes were
blocked in 5% (w/v) non-fat milk for 1 h and then incu-
bated with rabbit anti-p-HSL (Cell Signaling, Beverly,
MA, USA; 1:1000 dilution), rabbit anti-HSL (Cell Signal-
ing, Beverly, MA, USA; 1:1000 dilution), rabbit anti-
ATGL (Cell Signaling, Beverly, MA, USA; 1:1000 dilu-
tion), rabbit anti-p-AMPK (Thr 172), rabbit anti-AMPK
(Cell Signaling, Beverly, MA, USA; 1:1000 dilution), rabbit
anti-PPARγ (Millipore, USA; 1:1000 dilution) or mouse
anti-β-actin (Proteintech, Chicago, IL, USA; 1:2000 dilu-
tion) primary antibodies overnight at 4 °C. The mem-
branes were then incubated with peroxidase-conjugated
anti-rabbit or anti-mouse secondary antibody for 1 h at
room temperature. After washing with TBST, the immune
complexes were detected using the Alpha Q Chemilumin-
escence System and exposed to film. The relative intensity
of the target protein to HSL or to β-actin in the same
sample was analyzed using the Alpha Q software.
RNA extraction and quantitative real-time PCR analysis
Total RNA was isolated from cells using TRIzol reagent
(Takara, Tokyo, Japan) according to the manufacturer’s
instructions. The RT reaction was carried out using
1 mg of total RNA. Real-time PCR was performed with the
Light Cycler 480 (Roche Applied Science, Indianapolis, IN).
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The following primer sequences were used: ATGL forward,
5′- GGATGAAAGAGCAGACGGGTAG -3′, and reverse,
5′-CGCAAGACAGTGGCACAGAG -3′, HSL forward 5′-
ACTGAGATTGAGGTGCTGTC - 3′, and reverse, 5′-AG
GTGAGATGGTAACTGTGAG - 3′, and β-actin forward,
5′-ACCCCAGCCATGTACGTAGC-3′, and reverse, 5′-
GTGTGGGTGACCCCGTCTC-3′. β-actin was employed
as an endogenous control for normalization.
Immunofluorescence
The cells were washed with PBS, fixed with 4% parafor-
maldehyde for 15 min, permeabilized with 0.2% Triton
X-100 for 5 min and blocked using 10% goat serum in
PBS for 30 min at room temperature. They were then
incubated with primary antibodies (rabbit anti- ATGL,
1:100 dilution) in blocking buffer overnight at 4 °C.
Next, the cells were incubated with secondary antibodies
(FITC- or TRITC-conjugated, 1:50 dilution; Zhongshan
Golden Bridge Biotechnology Co. Ltd) for 1 h at room
temperature. The nuclei of the cells were visualized
using mounting medium with DAPI. The fluorescence
levels of the cells were determined using a confocal
microscope (Axiovert 100 M Zeiss, Zeppelinstrasse,
Germany).
Statistical analysis
Data are presented as the mean ± standard error of the
mean (SEM). One-way analysis of variance (ANOVA)
Fig. 1 a Representative images of 3T3-L1 cells on D0 and D12 during the differentiated process and Oil red O staining of differentiated 3T3-L1
cells on D12. b TG content assay of 3T3-L1 cells on different day in the differentiated process. Intracellular TG contents were normalized by total
protein. c 3T3-L1 cells were induced to differentiated adipocytes according to the protocol. Proteins in the cells of different days on the differentiated
process were separated by SDS-PAGE and immunoblotted for PPARγand β-actin. Representative Western blot results are shown. The data were
presented as the mean ± SD. * p <0.05, **p <0.01 versus the group of D0
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and T tests were performed using the SPSS 13.0 soft-
ware package. A value of P <0.05 was considered to be
statistically significant.
Results
TG content of differentiated 3T3-L1 cells was significantly
decreased after BBR treatment
The 3T3-L1 cells, derived from mouse fibroblast cells,
could be induced to differentiate to adipocytes, which
are widely used in research studies concerning TG me-
tabolism and obesity. After differentiated, the TG con-
tent in differentiated 3T3-L1 cells is significantly
increased, as shown in Fig. 1a. The expression of PPARγ,
which is accepted as one of the standard makers of
mature adipocytes, increases during the differentiation
of 3T3-L1 cells, as shown in Fig. 1b. In this study,
differentiated 3T3-L1 cells were used to examine the
effects of BBR on TG content in vitro. Various con-
centrations of BBR, including 1 μM, 5 μM, 10 μM
and 100 μM, have been used in studies concerning
the lipolysis of differentiated 3T3-L1 cells [10]. In this
study, concentrations of 10 μM and 100 μM were
used. As shown in Fig. 2a, after treatment with BBR,
the number of the red-stained cells had decreased,
both by visual inspection and under microscopy. This
effect was confirmed by the results of the TG content
measured by colorimetric assay. When treated with
BBR concentrations of 10 μM and 100 μM, the intra-
cellular TG contents in differentiated 3T3-L1 cells
were reduced by 12.5 and 36.5%, respectively, as shown in
Fig. 2b. These results indicated that the metabolism of TG
in differentiated 3T3-L1 cells may be regulated by BBR.
To verify this hypothesis, the effects of BBR on the key
enzymes that regulate the metabolism of TG in 3T3-L1
cells were explored.
BBR increased the expression of p-HSL and ATGL in
differentiated 3T3-L1 adipocytes
Currently, it is widely accepted that GPAT3, ATGL and
HSL are rate-limiting enzymes involved in the metabol-
ism of TG in adipocytes. GPAT is the key enzyme
regulating the synthesis of TG [11], GPAT3 is the major
GPAT isoform expressed in adipocytes, and it plays a
crucial role in adipogenesis [12]. The protein expression
of GPAT3 in differentiated 3T3-L1 cells was not altered
significantly following treatment with BBR (Fig. 3a), and
we therefore focused on HSL and ATGL in this study. In
accordance with the results of Li bin Zhou [6], we found
that the expression of Ser563 p-HSL, which is phosphor-
ylated at Ser563 of HSL by protein kinase A (PKA), was
not affected by BBR (data not shown), while the
expression of Ser565 p-HSL, which is phosphorylated at
Ser565 by AMPK, increased after treatment with BBR,
as shown in Fig. 3a. It is a notable finding in this study
that BBR could significantly increase the protein expres-
sion of ATGL in differentiated 3T3-L1 cells (Fig. 3a).
The ATGL mRNA in differentiated 3T3-L1 cells was
also increased after treatment with BBR, as shown in
Fig. 3b. The effects of BBR on both Ser565 p-HSL and
ATGL were time-dependent.
AMPK pathway was involved in the effects of BBR on
p-HSL and ATGL in differentiated 3T3-L1 adipocytes
AMP-activated protein kinase (AMPK) plays a vital role
in energy metabolism and is a conserved regulator of
lipids metabolism. Compound C is a recognized AMPK
inhibitor. In this study, the expression of p-AMPK was
increased in mature 3T3-L1 adipocytes after treated with
BBR, as shown in Fig. 4a. While pretreatment with com-
pound C, which blocked the activity of AMPK, the pro-
tein expressions of ATGL and p-HSL in differentiated
3T3-L1 adipocytes treated by BBR were decreased com-
pared with those only treated with BBR, as shown in
Fig. 4b. Immunofluorescence analysis also certified these
Fig. 2 a Representative images of Oil red O staining and b TG
content assay of differentiated 3T3-L1 adipocytes treated with different
concentrations of BBR for 24 h. Intracellular TG contents were
normalized by total protein, and both originated from one
sample. The data were presented as the mean ± SD. * p <0.05,
**p <0.01 versus the control group. Original magnification: 400 ×
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Fig. 3 On D12, cells were treated with 10 μM and 100 μM BBR for 24 h or 48 h in serum-starved DMEM. a Proteins were separated by SDS-PAGE
and immunoblotted for p-HSL (Ser 565), HSL, ATGL, GPAT3 and β-actin. The values of p-HSL were quantified using densitometry and normalized
with HSL, while those of ATGL and GPAT3 were quantified by densitometry and normalized with β-actin. Representative Western blot results are
shown. b Total RNA was extracted from differentiated cells treated with 10 μM and 100 μM BBR for 24 h or 48 h in serum-free DMEM. mRNA
levels of ATGL and HSL were determined by real-time PCR and normalized with β-actin. Values are reported as the fold-change relative to the control
group. The data are from 3 independent experiments and are presented as the mean ± SD. * p <0.05 versus the control group, **p <0.01 versus the
control group
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results, as shown in Fig. 4c. These results showed that
the effects of BBR on ATGL and p-HSL were impaired
when pretreated with compound C, which indicated that
AMPK was involved in the process of BBR regulating
the expression of p-HSL and ATGL.
Discussion
The accumulation of TG in adipocytes causes obesity,
and therefore decreasing the TG content in adipocytes is
important for combating obesity. The present study
showed that BBR directly increased the expression of
ATGL in 3T3-L1 adipocytes and decreased the TG con-
tent in adipocytes. The beneficial effects of BBR on lip-
olysis have evoked substantial interest in the compound
as a potential treatment for obesity and diseases such as
diabetes.
Studies in mice have found that adipocytes decrease in
size after treatment with BBR, [9] which suggests that
BBR could decrease the accumulation of TG in adipo-
cytes. Our data confirmed this effect of BBR in vitro.
After treatment with BBR, lipid-drops in 3T3-L1 adipo-
cytes reduced significantly, both in numbers and in size.
To illustrate the mechanism of this effect, studies of the
rate-limiting enzymes regulating TG metabolism were
performed.
Activation of HSL is controlled by phosphorylation/
dephosphorylation events, which are regulated by
cAMP-dependent PKA and protein phosphatase, re-
spectively [13]. PKA phosphorylates HSL at Ser563 and
Ser660, which stimulates HSL to hydrolyze TG. In con-
trast, AMPK phosphorylates HSL at Ser565, which re-
duces HSL phosphorylation at Ser563 by PKA and
inhibits the activity of HSL. It has been reported that
neither Ser563 nor Ser660 are affected by BBR, while the
expression of Ser565 increases after treatment with BBR
[6], which was also shown in our study. As mentioned
above, HSL is the major lipase catalyzing the rate-
limiting step in stimulated lipolysis in adipocytes [3].
Taken together, all of these data suggest that do not
similar to catecholamines, BBR has minimal direct im-
pact on the acute effects of lipolysis.
ATGL is critical for the hydrolysis of TG during basal
lipolysis [3]. Our study showed that the expression of
ATGL in 3T3-L1 adipocytes significantly increased fol-
lowing treatment with BBR, which had not been re-
ported before. This finding may explain the decrease in
TG in 3T3-L1 adipocytes following treatment with BBR,
and it may partially account for the weight-loss effect of
BBR. That is, although the expression of p-HSL (Ser565)
is also significantly increased following stimulation by
Fig. 4 a On D12, cells were treated with 10 μM and 100 μM BBR for 24 h in serum-starved DMEM. Proteins were separated by SDS-PAGE and
immunoblotted for p-AMPK, AMPK and β-actin. The values of p-AMPK were quantified using densitometry and normalized with AMPK. Representative
Western blot results are shown. b On D12, the cells were stimulated with 20 μM Compound C or 10 μM BBR. After 1 h, the cells from one of the two
dishes pretreated with Compound C were exposed to 10 μM BBR. All cells were treated for 24 h in serum-free DMEM. Proteins were separated by SDS-
PAGE and immunoblotted for p-HSL, HSL, ATGL and β-actin. Values of p-HSL were quantified by densitometry and normalized with HSL while those of
ATGL were quantified by densitometry and normalized with β-actin. Representative Western blot results are shown. Values are reported as the fold-
change relative to the control group. c The visualization of ATGL by immunofluorescence staining (red). Nuclei were stained with DAPI (blue). Values
are reported as the fold-change relative to the control group. The data are from 3 independent experiments and are presented as the mean ± SD.
*p <0.05 versus the control group, **p <0.01 versus the control group. Original magnification: 400 ×
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BBR, the enhanced expression of ATGL increases the
basal lipolysis of TG in adipocytes, causing the TG con-
tent in adipocytes to decrease, leading to weight loss.
The effects of BBR on HSL and ATGL were similar to
those of thyrotropin (TSH). TSH has been found to ex-
hibit bidirectional effects on lipolysis. Studies have found
that TSH stimulated the expression of p-HSL (Ser563)
to stimulate lipolysis [14], while another study found
that TSH decreased the expression of ATGL to inhibit
basal lipolysis [15]. We therefore speculate that the ef-
fects of BBR on the enzymes regulating lipolysis may
also be bidirectional, and the detailed mechanism re-
quires further study. In this study, the effects of BBR on
p-HSL and ATGL were time-dependent rather than
dose-dependent, possibly because the most effective
concentration of BBR on 3T3-L1 cells was 10 μM [6], so
the effect of BBR with 100 μM was not significantly dif-
ferent compared with that of 10 μM.
AMPK is a common target of the pathways involving
energy metabolism. Both HSL and ATGL are phosphor-
ylated by AMPK [16]. Studies have found that BBR regu-
lated the metabolism of TG, cholesterol and glucose by
regulating the expression of AMPK [17, 18]. In our
study, the effects of BBR on p-HSL and ATGL were par-
tially blocked by Compound C, which suggests that
AMPK at least partially regulates the effects of BBR on
p-HSL and ATGL.
Besides the effect on the metabolism of TG, BBR has
also been found have the hypocholesterolemic effect
[19]. The mechanism of this effect involves proprotein
convertase subtilisin/kexin type 9(PCSK9) [20, 21] and
LDLR [22], which is distinguished with that of statins.
BBR, as an isoquinoline alkaloid, could be isolated from
many medicinal herbs such as Coptidis Rhizoma,
Hydrastis canadensis and Cortex Phellodendri. All of
these characteristics make BBR a potential nutraceutical
to treat dyslipidaemia [23].
Conclusions
This study illustrated the novel effect of BBR in increas-
ing the expression of ATGL in the mature adipocytes,
which confirmed the statement that BBR could regulate
the metabolism of TG. BBR can regulate the metabolism
of both TG and cholesterol, and further studies are
needed to explore the effects of BBR in regulating energy
metabolism. These studies may facilitate the develop-
ment of therapeutic strategies for the treatment of dys-
lipidemia and obesity.
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